EverSource Wealth Advisors’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46.4K	Sell	10,316 -153	-1%	-$797	﹤0.01%	1947
2025 Q4	$64.4K	Buy	10,469 +6,097	+139%	+$44.2K	﹤0.01%	1578
2025 Q3	$31.6K	Sell	4,372 -300	-6%	-$1.78K	﹤0.01%	2025
2025 Q2	$24.8K	Buy	4,672 +4,480	+2,333%	+$26.5K	﹤0.01%	2132
2025 Q1	$1.7K	Sell	192 -165	-46%	-$1.98K	﹤0.01%	2993
2024 Q4	$4.89K	Sell	357 -124	-26%	-$2.29K	﹤0.01%	2361
2024 Q3	$13.2K	Hold	481	–	–	﹤0.01%	1714
2024 Q2	$13.5K	Buy	481 +13	+3%	+$285	﹤0.01%	1704
2024 Q1	$9.16K	Buy	468 +5	+1%	+$107	﹤0.01%	1735
2023 Q4	$8.86K	Buy	463 +241	+109%	+$4.17K	﹤0.01%	1615
2023 Q3	$3.56K	Sell	222 -645	-74%	-$12.3K	﹤0.01%	1827
2023 Q2	$20.1K	Buy	867 +155	+22%	+$3.38K	﹤0.01%	1150
2023 Q1	$16.5K	Buy	712 +273	+62%	+$5.54K	﹤0.01%	1153
2022 Q4	$6.37K	Sell	439 -69	-14%	-$1.29K	﹤0.01%	1506
2022 Q3	$9K	Buy	+508	New	+$11.7K	﹤0.01%	1158